Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population
Amina M. Bagher1★, Wedyan S. Alharbi2, Lamees S. Gadi2, Lenah S. Binmahfouz1, Rawan H Hareeri1★ Corresponding author
- 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
- 2Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
CORRESPONDENCE
Amina M. Bagher
Department of Pharmacology and Toxicology, King Abdulaziz University Jeddah, Makkah 21589, Saudi Arabia.
Received: 06-04-2023; Revised: 10-06-2023; Accepted: 12-06-2023.
Volume 14, Issue 2 · pp. 125–132 · PUBLISHED 2023 · DOI: 10.1177/0976500X231189351
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Objectives: To investigate the allele and genotype frequencies of the warfarin-related genes VKORC1 (-1639G>A), CYP2C9*2, and CYP2C9*3 among healthy Saudis. Materials and Methods: This cross-sectional study involved 125 unrelated healthy Saudis ages 18–60 years visiting the King Abdulaziz University Hospital (KAUH) in Jeddah, Western Saudi Arabia. The Oragene™ DNA saliva collection kits were used to collect and extract DNA from saliva samples. A polymerase chain reaction-restriction fragment length polymorphism analysis was used to detect the mutant alleles. Results: Over 51.4% of the Saudi participants carried one or more mutant alleles. The frequency of the VKORC1 (-1639G>A) allele in Saudi was relatively high at 54.8%. The frequencies of the CYP2C9 allele were 19.6% and 54% for the CYP2C9*2 and CYP2C9*3 alleles, respectively, which are substantially more abundant than in other populations. Conclusion: The observed high frequencies of VKORC1 (-1639G>A) and CYP2C9*2 and CYP2C9*3 polymorphisms suggest that genetic testing should be considered before initiating warfarin therapy to predict the optimal initial dose of warfarin and minimize warfarin-related side effects.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Bagher, A. M., Alharbi, W. S., Gadi, L. S., Binmahfouz, L. S., & Hareeri, R. H. (2023). Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population. Journal of Pharmacology and Pharmacotherapeutics, 14(2), 125–132. https://doi.org/10.1177/0976500X231189351
